Anokion Company

Anokion is a company that originated from EPFL and specializes in using their antigen-specific immune tolerance technology to decrease the immunogenicity of therapeutic proteins and address autoimmune and allergic diseases. Their technology can be applied to various proteins for different medical conditions.


Estimated Revenue: $35 Million
Headquarters: Vaud
Industry: PharmTech
Employee Number: 11-50